Vanda Pharmaceuticals
VNDA
#7640
Rank
โ‚น37.85 B
Marketcap
โ‚น640.48
Share price
0.74%
Change (1 day)
69.86%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚น10.47 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2024 the company made an earning of -โ‚น3.82 Billion a decrease over its 2023 earnings that were of -โ‚น1.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.47 Billion174.54%
2024 -โ‚น3.82 Billion191.43%
2023 -โ‚น1.31 Billion-320.45%
2022 โ‚น0.59 B-84.99%
2021 โ‚น3.95 B54.8%
2020 โ‚น2.55 B19.42%
2019 โ‚น2.13 B4.93%
2018 โ‚น2.03 B-228.6%
2017 -โ‚น1.59 Billion-8.98%
2016 -โ‚น1.75 Billion-53.79%
2015 -โ‚น3.77 Billion-30.18%
2014 -โ‚น5.4 Billion173.08%
2013 -โ‚น1.98 Billion-25.33%
2012 -โ‚น2.65 Billion163.61%
2011 -โ‚น1.01 Billion-221.15%
2010 โ‚น0.82 B-124.53%
2009 -โ‚น3.38 Billion-29.44%
2008 -โ‚น4.79 Billion-36.2%
2007 -โ‚น7.51 Billion21.81%
2006 -โ‚น6.17 Billion170.55%
2005 -โ‚น2.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.146 T-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.533 T-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น955.75 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.412 T-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.102 T-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น874.73 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.27 Billion-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA